LMT vs TARS · P/E 20, rev $20.06B vs rev $336.0M
Lockheed Martin Corporation (LMT) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported LMT revenue for 2026-06-28 was $20.06B. Net income was $1.84B. Revenue was up 11.3% from 2026-03-29 to 2026-06-28. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
LMT currently screens at market cap $108.37B and trailing P/E 19.9. TARS currently screens at market cap $2.66B.
Not investment advice. Open the LMT and TARS stock pages for the full models.
Not investment advice.